Published 2 years ago

New Therapy Improves Cognition in Down Syndrome Patients

Summary by Ground News

Pulsatile GnRH therapy improves cognitive function and neural connectivity in a small patient group. Seven men with Down syndrome, between 20 and 50 years of age, received one subcutaneous dose of GnRH every two hours for 6 months via a pump placed on the arm. Cognition and olfactory tests as well as MRI exams were performed before and after treatment.

0 Articles

All

Left

Center

Right

Sci Tech Daily

New Therapy Improves Cognition in Down Syndrome Patients

A new treatment has been shown to improve cognitive function. In order to enhance the cognitive abilities of a small sample of Down syndrome patients, an Inserm team at the Lille Neuroscience & Cognition laboratory (Inserm/Université de Lille, Lille University Hospital) has collaborated with t

2 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.